Back to Search Start Over

10 practical priorities to prevent and manage serious allergic reactions: GA 2 LEN ANACare and EFA Anaphylaxis Manifesto.

Authors :
Muraro A
de Silva D
Podesta M
Anagnostou A
Cardona V
Halken S
Smith P
Tanno LK
Turner P
Worm M
Alvaro-Lozano M
Arasi S
Asarnoj A
Barni S
Beyer K
Bilaver LA
Bird A
Bonaguro R
Brough HA
Chinthrajah RS
Cook EE
Demoulin C
Deschildre A
Dribin TE
Ebisawa M
Fernandez-Rivas M
Fiocchi A
Fleischer DM
Garrow E
Gerdts J
Giovannini M
Järvinen KM
Kelly M
Knol EF
Lack G
Lazzarotto F
Le TM
Leonard S
Lieberman J
Makris M
Mandelbaum L
Marchisotto MJ
Marino GA
Mori F
Nilsson C
Nowak-Wegrzyn A
Odemyr M
Oude Elberink HNG
Palosuo K
Patel N
Pier J
Poblete S
Rachid R
Rodríguez Del Río P
Said M
Sampson HA
Sánchez Sanz A
Schnadt S
Schultz F
Toniolo A
Upton JEM
Venter C
Vickery BP
Vlieg-Boerstra B
Wang J
Roberts G
Zuberbier T
Source :
Clinical and translational allergy [Clin Transl Allergy] 2024 Dec; Vol. 14 (12), pp. e70009.
Publication Year :
2024

Abstract

This Anaphylaxis Manifesto calls on communities to prioritise 10 practical actions to improve the lives of people at risk of serious allergic reactions. The Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA) compiled patient-centric priorities. We used qualitative consensus methods, research evidence and feedback from over 200 patient groups, stakeholder organisations and healthcare professionals. We encourage healthcare, education and food organisations to collaborate with people at risk of serious allergic reactions to tackle safety, anxiety and financial burdens for individuals and societies. Key priorities for prevention include awareness-raising campaigns for the public and professionals, school and workplace initiatives and mandatory precautionary allergen labels on food. Priorities for improving immediate and long-term management include educating healthcare professionals, patients and schools about when and how to use adrenaline, funding two approved adrenaline devices for everyone at risk, and facilitating access to allergy specialists. Integrated care pathways should include clinical and non-clinical management options such as individualised risk assessment and quality of life assessment, self-management plans, dietetic and psychosocial support and peer support. Organisations around the world are committing to work together towards these priorities.<br /> (© 2024 The Author(s). Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.)

Details

Language :
English
ISSN :
2045-7022
Volume :
14
Issue :
12
Database :
MEDLINE
Journal :
Clinical and translational allergy
Publication Type :
Academic Journal
Accession number :
39614094
Full Text :
https://doi.org/10.1002/clt2.70009